Sphingosine kinase 1 could enhance stem cell therapy efficiency for neurodegenerative diseases through induction of HIF-1

2020 ◽  
Vol 131 (1) ◽  
pp. 102-104
Author(s):  
Saeideh Gholamzadeh Khoei ◽  
Nashmin Fayazi ◽  
Rezvan Najafi
2021 ◽  
Vol 22 (4) ◽  
pp. 2153
Author(s):  
Farzane Sivandzade ◽  
Luca Cucullo

Neurodegenerative diseases resulting from the progressive loss of structure and/or function of neurons contribute to different paralysis degrees and loss of cognition and sensation. The lack of successful curative therapies for neurodegenerative disorders leads to a considerable burden on society and a high economic impact. Over the past 20 years, regenerative cell therapy, also known as stem cell therapy, has provided an excellent opportunity to investigate potentially powerful innovative strategies for treating neurodegenerative diseases. This is due to stem cells’ capability to repair injured neuronal tissue by replacing the damaged or lost cells with differentiated cells, providing a conducive environment that is in favor of regeneration, or protecting the existing healthy neurons and glial cells from further damage. Thus, in this review, the various types of stem cells, the current knowledge of stem-cell-based therapies in neurodegenerative diseases, and the recent advances in this field are summarized. Indeed, a better understanding and further studies of stem cell technologies cause progress into realistic and efficacious treatments of neurodegenerative disorders.


2004 ◽  
Vol 13 (1) ◽  
pp. 121-131 ◽  
Author(s):  
Lidia Cova ◽  
Antonia Ratti ◽  
Manuela Volta ◽  
Isabella Fogh ◽  
Veronica Cardin ◽  
...  

2016 ◽  
Vol 1 (1) ◽  
pp. 3 ◽  
Author(s):  
Mahdi Mirahmadi ◽  
Habib Rezanejadbardaji ◽  
Muhammad Irfan-Maqsood ◽  
Mohammad Javad Mokhtari ◽  
Hojjat Naderi-Meshkin

2015 ◽  
Vol 35 (4) ◽  
pp. 229 ◽  
Author(s):  
Jong Zin Yee ◽  
Ki-Wook Oh ◽  
Seung Hyun Kim

Sign in / Sign up

Export Citation Format

Share Document